14th to 17th September 2015
AstraZeneca, Alderley Park, Macclesfield, UK.
Piet van der Graaf (Leiden)         Oleg Demin (Moscow)           Sandra Visser (Merck)           Blanca Rodriguez (Oxford)
This 4 day meeting, kindly supported by AstraZeneca, Pfizer and Unilever, will provide an introduction to QSP and a forum for researchers in academia and industry to come together to discuss development in this emerging field of science in the UK and internationally. The meeting will showcase current advances in the field (Day 1) and provide the opportunity for mathematicians, engineers, scientists and industrialists to exchange skills and knowledge by working on problems brought by life scientists in industry and academia (Days 2 to 4).
An abstract modelling framework for adverse outcome pathways
Understanding polypharmacology of antibodies: what are the benefits
of using a bispecific vs combination of monospecifics?
Registration for this meeting has now closed.
Organising Committee: Marcus Tindall (Reading), Leon Aarons (Manchester), Mike Chappell (Warwick),
Lourdes Cucurull-Sanchez (GlaxoSmithKline), Gianne Derks (Surrey), Pinky Dua (Pfizer), Ben Whalley (Reading) and
James Yates (AstraZeneca).